Toronto Dominion Bank Apellis Pharmaceuticals, Inc. Transaction History
Toronto Dominion Bank
- $49.5 Billion
- Q1 2025
A detailed history of Toronto Dominion Bank transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 162,190 shares of APLS stock, worth $3.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
162,190
Previous 997,053
83.73%
Holding current value
$3.1 Million
Previous $31.8 Million
88.85%
% of portfolio
0.01%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$235 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$234 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$228 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$194 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$184 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.1B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...